KLF15 and Hepatic steatosis: Interestingly, HFD-induced systemic and hepatic insulin resistance is ameliorated by genetic interventions targeting Klf15. Moreover, while an ER stress activator, tunicamycin, induces liver steatosis and insulin resistance, these hepatic responses are much reduced in Klf15−/− mice.